Work with Apteka
Apteka intentionally works with a small number of organizations at a time — here's how to figure out where you fit.
Policy & Access Clarity Session.
A new rule drops and you need to know what it means before Monday. Or you’ve got a leadership briefing and need to get smart fast. This is 90 minutes, one specific question, and a clear answer you can act on immediately.
Best for: One urgent question, C-suite briefing prep, or a decision that can’t wait.
Policy Intelligence Briefing.
Your team needs to stay current on policy developments but doesn’t have the bandwidth to track everything. This is structured, recurring intelligence, not custom advisory.
Group Briefing
Monthly webinars on what actually matters, recording access if you can’t attend live, and blinded participation for competitive privacy.
Best for: Teams that need to stay informed but have more limited resources.
Custom Briefing
The same intelligence, tailored to your portfolio. Includes a prep call, a personalized monthly briefing, and Q&A. Your team, your questions, no blinding restrictions.
Best for: Organizations that want policy intelligence specific to their business and informed policy discussions.
Jennifer brings a political insider’s perspective that greatly enhances the value of her content. Jennifer has been a tremendous asset to my company by presenting healthcare policy updates (which were many in 2025!) that affect the business of the life science industry. As well, she has synthesized the content so that the information we receive is relevant and customized to my company’s specific business needs. I highly recommend her services.
— VP, Patient Group and Leader of National Coalition
Strategic Advisory.
This is where most ongoing relationships live. You’re not just staying current, you need someone helping you think through what developments mean for your portfolio, your patients, and your strategy. Memos, decks, coalition calls at the level the room expects. You get counsel and capacity without adding headcount.
Best for: Organizations that need regular, customized guidance and support.
Executive Advisory.
For the moments that define careers. A major launch, a regulatory shift that changes the math, a board that needs answers. Direct access, strategic counsel, executive coaching, and board prep. When something moves, Apteka is there.
Best for: Senior leaders making high-stakes decisions where getting the policy read wrong carries real consequences.
Policy Shaping.
You have a position. You need it to land.
Whether it’s a white paper that needs to hold up to scrutiny, an issue brief that shapes a comment period, or a keynote that moves a room, the result is positioning that carries independent credibility, not just internal conviction.
Best for: Organizations that want to shape policy discourse and need an independent, credible voice to make the argument land.
Speaking Engagements.
- Industry Depth.
25+ years across government, pharma, and consulting.
- Executive Leadership.
Former VP managing a $10M service line.
- Top Pharma Trust.
Trusted by 30+ of the Top 50 pharma companies.
Your Audience Leaves With Answers, Not Just Awareness
Most policy speakers give you the landscape. Jennifer gives your audience the full picture, what’s changing, who it affects, and what to do about it. Practical. Non-ideological. Patient-forward.
Speaking Formats.
-
Keynotes & Conference Sessions
Pharma conferences, industry summits, policy events. -
Internal Meetings.
Leadership teams and cross-functional groups that need an outside expert. -
Workshops.
Hands-on sessions where teams align on what matters and how to prioritize. -
Panels & Fireside Chats.
Substance and accessibility in any format. -
Webinars & Virtual Events.
The same depth and clarity, delivered remotely for distributed teams and virtual conferences.
Potential Topics.
State of the Union: U.S. Pharmaceutical Policy and What It Means for You
The major legislative, regulatory, and executive branch developments, with a clear “here’s what this means for your organization” through-line. This is the talk organizers request again and again because it’s genuinely useful and it changes every time.
Apteka also covers the IRA and drug pricing negotiations, PBM reform, patient access strategy, and proactive policy positioning for advocacy organizations. Every talk is customized to your audience.
Best for: Annual meetings, industry conferences, keynote stages
Stop the Swirl: Turning Policy Chaos Into Commercial Clarity.
A throwaway line in an investor report can trigger 60 people scrambling. Your audience will leave with a framework for knowing what actually matters, so they stop reacting to everything and start getting ahead of it.
Best for: Pharma brand, access, and policy teams
The Part D Redesign Didn't Just Change Copays. It Changed Your Business Model.
Most commercial teams understood the out-of-pocket cap. Far fewer understood what the redesign did to manufacturer liability in the catastrophic phase. Your audience will leave knowing what they may have missed, and what it means for how they price, contract, and forecast.
Best for: Pharma commercial and market access teams
340B Is Not a Drug Pricing Fight. It's a System Design Fight.
Your audience will understand why the 340B debate keeps going in circles, what manufacturer restrictions are actually doing in the courts, and what a productive path forward looks like for both pharma and patient advocates.
Best for: Mixed or advocacy-heavy audiences
Policy,
to the point.
Actions
Socials
© 2026 Apteka. All rights reserved.
